Autobio Diagnostics Co Ltd (603658) — Capital Reinvestment Ratio
Autobio Diagnostics Co Ltd (603658) has a Capital Reinvestment Ratio of 0.32x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥435.24 Million) in capital expenditures (CN¥138.47 Million). See Autobio Diagnostics Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Autobio Diagnostics Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Autobio Diagnostics Co Ltd's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Autobio Diagnostics Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Autobio Diagnostics Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see Autobio Diagnostics Co Ltd (603658) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.51x | CN¥1.31 Billion | CN¥664.40 Million | ▼ -17.2% |
| 2023 | 0.61x | CN¥1.47 Billion | CN¥900.42 Million | ▲ +1.7% |
| 2022 | 0.60x | CN¥1.56 Billion | CN¥938.32 Million | ▼ -17.5% |
| 2021 | 0.73x | CN¥1.46 Billion | CN¥1.07 Billion | ▼ -34.9% |
| 2020 | 1.12x | CN¥994.71 Million | CN¥1.12 Billion | ▲ +24.0% |
| 2019 | 0.90x | CN¥842.89 Million | CN¥762.07 Million | ▲ +44.1% |
| 2018 | 0.63x | CN¥653.73 Million | CN¥410.17 Million | ▼ -33.6% |
| 2017 | 0.94x | CN¥481.73 Million | CN¥455.17 Million | ▲ +65.5% |
| 2016 | 0.57x | CN¥415.82 Million | CN¥237.42 Million | ▼ -20.6% |
| 2015 | 0.72x | CN¥308.63 Million | CN¥221.81 Million | ▲ +3.1% |
| 2014 | 0.70x | CN¥256.93 Million | CN¥179.06 Million | ▼ -5.7% |
| 2013 | 0.74x | CN¥103.22 Million | CN¥76.32 Million | ▲ +82.1% |
| 2012 | 0.41x | CN¥69.32 Million | CN¥28.14 Million | ▼ -52.1% |
| 2011 | 0.85x | CN¥50.59 Million | CN¥42.84 Million | — |